According to 36Kr.com, Sailegene, a company providing bioinformatics solutions to medical, genetic sequencing and scientific institutions, has received nearly 10 million yuan (equal to US$1.4 million) in the angel round of financing in January 2019, with participation from Plum Ventures and New Potential Energy Fund. Currently, Sailegene is getting a new round of financing for new product development and marketing.
Sailegene is committed to providing super-fast, high-precision and low-cost bioinformatics data analysis solutions to global clients. Combining cutting-edge bioinformatics and IT technologies, the company has launched the BaseNumber NGS data analysis platform and a series of NGS secondary analysis processes, which increased the analysis speed and flux of NGS data by more than 100 times and significantly reduced the analysis cost.
Based on the heterogeneous computing architecture of "CPU+GPU", after dozens of upgrades, Sailegene has developed the BaseNumber NGS data analysis platform and launched an all-in-one machine with hardware. According to Zhang Jixiang, the co-founder and COO of the company, this platform follows the technology route of GPU and works on the GFrame technology framework based on CUDA. Moreover, according to the characteristics of genetic data, they have reconstructed the core biological information algorithm.
Sailegene has solved the technical problem of realizing the ultra-high-speed analysis of genetic data on the heterogeneous computing platform of CPU+GPU, and significantly improved the analysis speed under the premise of accuracy.
About Plum Ventures
Founded in May 2014, Plum Ventures is one of the most active investment institutions in China. It is committed to helping entrepreneurs in the field of the new economy. The company manages funds of 3 billion yuan and has participated in more than 300 investment projects.
About New Potential Energy Fund
New Potential Energy Fund focuses on investments in TMT, new retail, new finance, new manufacturing, new technology, new energy and health care, which are the most important development industries about economic transformation and consumption upgrading in China today. In 2018, the company managed three funds with a scale of more than 200 million yuan.